The Efficacy and Safety of Busulfan-Etoposide-Melphalan Regimen in Autologous Stem Cell Transplantation in Relapsed/ Refractory Hodgkin and Non-Hodgkin Lymphoma Patients: “A Single-Center Experience”

Abstract

Address for Correspondence/Yazışma Adresi: Ali Eser MD, Bezmialem Vakıf University Faculty of Medicine, Department of Hematology, İstanbul, Turkey Phone: +90 212 453 17 00 E-mail: [email protected] ORCID ID: orcid.org/0000-0001-9423-928X Cite this article as/Atıf: Eser A, Timurağaoğlu A. The Efficacy and Safety of Busulfan-Etoposide-Melphalan Regimen in Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma Patients: “A Single-Center Experience”. İstanbul Med J 2021; 22(2): 133-9. Received/Geliş Tarihi: 30.11.2020 Accepted/Kabul Tarihi: 01.03.2021 Ali Eser1, Ayşen Timurağaoğlu2 1Bezmialem Vakıf University Faculty of Medicine, Department of Hematology, İstanbul, Turkey 2Hisar Intercontinental Hospital, Clinic of Hematopoietic Stem Cell Tranplantation, İstanbul, Turkey